TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV)

Clinical trials for TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV) explained in plain language.

Never miss a new study

Get alerted when new TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV) trials appear

Sign up with your email to follow new studies for TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Triple threat: new vaccine aims to tackle three salmonella strains at once

⭐️ VACCINE ⭐️ Ongoing

This study tests a new vaccine designed to protect against three common types of Salmonella bacteria that cause serious infections in Sub-Saharan Africa. The trial includes healthy participants ranging from adults down to young infants, and compares the vaccine to a placebo to se…

Matched conditions: TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV)

Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ VACCINE ⭐️

Last updated Jul 01, 2026 00:00 UTC

TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV)

Get alerted when new TRIVALENT SALMONELLA CONJUGATE VACCINE (TSCV) trials appear

Triple threat: new vaccine aims to tackle three salmonella strains at once